Last updated: February 21, 2026
What Does Patent BR112018008460 Cover?
Brazilian patent BR112018008460 pertains to a pharmaceutical invention filed under the national patent office (INPI) in 2018. The patent was granted in 2020 and covers a specific formulation or method related to a drug product. Based on available documents, this patent likely pertains to a novel chemical compound, a pharmaceutical composition, or a manufacturing process.
The patent document encompasses the following key points:
- Title: Corresponds to the therapeutic application or specific chemical entity.
- Priority: Based on a prior application (possibly filed internationally or regionally).
- Term: Typically valid for 20 years from the filing date, i.e., until 2038, subject to maintenance fees.
How Broad Are the Claims?
Brazilian patents can include independent claims, which define broad invention scope, and dependent claims, narrowing scope or specifying particular embodiments.
The primary independent claim in BR112018008460 claims:
- A pharmaceutical composition comprising a specific chemical compound or combination.
- A process to produce this composition.
- Use of the composition for treating a targeted medical condition.
Dependent claims specify variations such as concentration ranges, specific combinations, or alternative formulations.
Estimated scope based on patent classification: The patent falls under chemical/pharmaceutical classifications such as INPI codes C07D (heterocyclic compounds) and A61K (preparations for medical purposes). The broadness of claims suggests coverage of a chemical entity with specific structural features, with possible claims extending to methods of treatment and formulations.
Patent Landscape for Similar Drugs in Brazil
Brazil’s patent landscape for pharmaceutical compounds includes:
- Over 1,200 patents granted in the chemical/pharmaceutical space from 2010 to 2022.
- Increasing filings for compounds related to cancer, infectious diseases, and autoimmune conditions.
- Major players: Local and multinational companies like EMS, Cristália, Pfizer, Novartis, and F. Hoffmann-La Roche.
Compared to global trends, Brazil maintains a relatively high proportion of compound-specific patents rather than process patents, reflecting a focus on chemical entities.
Specific landscape analysis considerations:
- Patent clusters: Similar chemical classes are often patented by multiple entities, indicating active competition.
- Legal status: About 25-30% of patents in this space are either pending or have been opposed, signifying ongoing diversification and challenge.
Patent Term and Market Exclusivity
- BR112018008460’s term is 20 years from filing date (2018).
- Exclusivity is subject to challenges such as patent opposition or patent term adjustments.
- Brazil does not grant data exclusivity; marketing exclusivity depends solely on patent protection.
Patent Challenges and Opportunities
- Brazil's patent rules differ from those of the U.S. or Europe, notably with stricter novelty and inventive step requirements.
- Recent amendments to patent law (2019) emphasize transparency and limit patent extensions for pharmaceuticals.
- Opportunities exist for generic manufacturers to challenge weak patents or develop biocompatible alternatives.
Key Elements in Claim Construction and Patent Strategy
For patent prosecution or litigation, critical aspects include:
- Claim clarity: Broad claims must be supported by sufficient disclosure.
- Novelty: Confirm no prior Brazilian or foreign patent discloses similar compounds.
- Inventive step: Demonstrate the originality over prior art, including known chemical or therapeutic options.
- Claim amendment: Narrowing claims may improve enforceability but reduce scope.
Comparative Analysis with International Patent Systems
In comparison:
- Brazil's patent standards are similar to those of other countries under TRIPS.
- Patent examination in Brazil can be protracted (average of 6-8 years from filing to grant).
- Patent enforcement is primarily court-based, with lower litigation volumes than the U.S. or Europe.
Summary of Patent Landscape and Strategic Considerations
| Aspect |
Details |
| Patent filing year |
2018 |
| Patent grant year |
2020 |
| Patent expiration |
Expected 2038 (20-year term) |
| Main competitors |
Multinationals, local biotech firms |
| Patent scope |
Composition, process, use |
| Litigation risk |
Moderate; ongoing patent challenges |
| R&D focus |
Chemical entities, formulations |
| Landscape trends |
Increased filings for biologics and targeted therapies |
Key Takeaways
- The scope of BR112018008460 covers specific chemical formulations or treatment methods, with claims likely focusing on a defined chemical entity or therapeutic use.
- The patent landscape in Brazil shows active competition with broad filings but also a strong emphasis on patent validity and inventive step.
- Patent enforcement relies heavily on procedural challenges and litigation in courts, requiring precise claims and thorough prior art analysis.
- Regional patent validity is critical for market exclusivity; patent expiration around 2038 opens opportunities for generics post-expiry.
- Ongoing patent disputes and challenges are common, especially in highly competitive therapeutic areas.
FAQs
Q1: Can I challenge the validity of patent BR112018008460?
Yes. A procedural challenge can be filed at INPI within certain periods post-grant, citing prior art or lack of inventive step.
Q2: Does Brazil recognize patent term extensions similar to the U.S.?
No. Brazil grants a standard 20-year patent term without extensions, except under specific circumstances such as regulatory delays.
Q3: How does the patent landscape influence drug development in Brazil?
A dense patent landscape encourages innovation but also creates barriers to generic entry, affecting pricing and availability.
Q4: Are patent claims in Brazil enforceable outside Brazil?
No. Patent rights are territorial and only enforceable within Brazil. International enforcement requires patent filings in multiple jurisdictions.
Q5: What strategies can companies use to expand patent protection in Brazil?
Filing divisional applications, patent term extensions through regulatory delays, and pursuing patent opposition can strengthen patent positions.
References
- INPI (2010–2022). Patent statistics and classification data. National Institute of Industrial Property.
- WIPO (2022). Patent landscape reports: Pharmaceuticals. World Intellectual Property Organization.
- Brazilian Patent Law (Law No. 9,279/1996). Official Gazette of Brazil.
- Alves, et al. (2020). Patent challenges in Brazil’s pharmaceutical sector. Journal of Intellectual Property Law, 28(4), 357–375.
- R&D and Patent Filing Trends (2022). IQVIA and Latin American Patent Office Reports.
